arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Hyperfine, Inc.

HYPR
$0.95 ▼ -0.03 (-3.40%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
7 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

Hyperfine, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $77.7M
Dividend Yield
Revenue Growth 5.2%
Op. Margin -273.4%
ROIC -90.4%
FCF / Share $-0.36
Trailing P/E
Price / Book 1.9x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$13.56M
↑ +5.2%
Net Income Profit after all expenses
$-35.57M
↑ +12.6%
Operating Margin Operating profit as % of sales
-273.4%
↑ +18.5% 0th
FCF / Share Free cash flow per share
$-0.36
↑ +34.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
1
Returns
11
Cash Quality
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 23 quarters